> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Drug Outsourcing Facility User Fees Set for FY 2023
- URL: https://www.fdaweb.com/drug-outsourcing-facility-user-fees-set-for-fy-2023/
- Published: 2022-07-28T12:00:00.000Z
- Updated: 2026-09-14T17:53:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5152389

*Federal Register* notice FDA is announcing the fiscal year 2023 rates for the establishment and reinspection fees related to entities that compound human drugs and elect to register as outsourcing facilities. The small business establishment fee is $5,941, non-small business establishment fee is $18,661, and the reinspection fee is $17,823\. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-07-28/pdf/2022-16170.pdf?ref=fdaweb.com).